TotalMarketCap

Edgewise Therapeutics

EWTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.256 B

$38.87 +3.57%

Close of 6 Nov 2026

As of 6 Nov 2026, Edgewise Therapeutics (EWTX) has a market capitalization of $4.26B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$167.8K

Loss-making

Shares outstanding

109,482,763

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #57ErascaERAS$4.64B
  2. #58Legend BiotechLEGN$4.39B
  3. #59Edgewise TherapeuticsEWTX$4.26B
  4. #60LiquidiaLQDA$3.98B
  5. #61Xenon PharmaceuticalsXENE$3.66B

What if Edgewise Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$257,911.59

Per share 6,635× higher

Bitcoin $1.53T

$13,955.15

Per share 359× higher

Apple $5.02T

$45,813.45

Per share 1,179× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Edgewise Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.